Page last updated: 2024-10-29

incadronate and Hypercalcemia

incadronate has been researched along with Hypercalcemia in 1 studies

Hypercalcemia: Abnormally high level of calcium in the blood.

Research Excerpts

ExcerptRelevanceReference
"Zoledronic acid (6i) has thus been selected for clinical development under the registered trade name Zometa."1.31Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). ( Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Widler, L1
Jaeggi, KA1
Glatt, M1
Müller, K1
Bachmann, R1
Bisping, M1
Born, AR1
Cortesi, R1
Guiglia, G1
Jeker, H1
Klein, R1
Ramseier, U1
Schmid, J1
Schreiber, G1
Seltenmeyer, Y1
Green, JR1

Other Studies

1 other study available for incadronate and Hypercalcemia

ArticleYear
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
    Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

    Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques

2002